CD8A and neoplasm: The role of CD8+ T cells in the Th9 cell-induced anti-tumor effect observed in vivo was reinforced by the observation that abrogating the function of CD8+ T cells with anti-CD8 antibodies reversed tumor rejection in a mouse model (Figure 2).